Single surface protein boosts multiple oncogenic pathways in acute myeloid leukemia

Researchers have discovered that a signaling protein elevated in patients with acute myeloid leukemia (AML) plays a much wider role in the disease than previously thought. The study raises hopes that current efforts to target this signaling protein could be a successful strategy to treat AML and other blood cancers.

Click here to visit Original posting

Bookmark the permalink.

Comments are closed.